How Depression Changes Your Brain: The Neuroscience Explained

Depression is not simply a mood. Research confirms that major depressive disorder produces measurable structural and chemical changes in the brain. These changes can persist long after acute symptoms begin and that standard antidepressants do not always fully reverse (Mayo Clinic). Understanding what is actually happening inside a depressed brain helps explain why so many people find that standard treatments provide only partial relief, and why a different pharmacological approach may be warranted. At Soft Reboot Wellness in Menlo Park, this neuroscience is not background reading. It is the foundation of how we think about treatment.

What Depression Does to Brain Chemistry

The most familiar story about depression involves serotonin: not enough of it, and mood suffers. That account is not wrong, but it is incomplete. Depression disrupts multiple neurotransmitter systems simultaneously, and the downstream consequences extend well beyond how a person feels on a given day.

Among the most significant changes is what happens to BDNF (brain-derived neurotrophic factor), a protein that supports the growth, survival, and maintenance of neurons (brain cells). In people with depression, BDNF levels are often markedly reduced. This matters because BDNF is essentially the brain’s maintenance crew: without adequate levels, neurons in mood-regulating regions begin to atrophy, synaptic connections weaken, and the brain’s capacity to adapt and recover is compromised. Research has shown that ketamine directly increases BDNF, which may explain part of its rapid antidepressant effect (National Institutes of Health).

The hippocampus, a brain region central to memory formation and emotional regulation, is particularly vulnerable to these changes. Studies show that prolonged depression can actually reduce hippocampal volume, contributing to the memory difficulties and cognitive fog that many patients describe alongside low mood (National Institutes of Health). For Silicon Valley professionals who rely on sharp thinking, this aspect of depression’s neurological footprint is often deeply disruptive.

The Glutamate Gap That SSRIs Don’t Fill

First-line antidepressants, SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors), work by increasing the availability of serotonin and norepinephrine at synapses. They help a significant portion of people with depression, and we respect their role in treatment (National Institutes of Health). But they operate on a specific subset of the brain’s chemistry, and for patients whose depression involves substantial glutamate system dysregulation, serotonin-targeted treatment may simply not be addressing the right problem.

Glutamate is the brain’s primary excitatory neurotransmitter, it drives the vast majority of signaling between neurons. When the glutamate system is dysregulated, as appears to be the case in many forms of treatment-resistant depression, the brain loses some of its capacity for neuroplasticity: the ability to form new connections, reorganize existing pathways, and recover from damage. This is the gap that has made a growing number of clinicians and patients look past the standard antidepressant toolkit.

At Soft Reboot Wellness, Dr. Sara Herman, a Harvard-trained anesthesiologist who has guided more than 10,000 patients through anesthesia and ketamine therapy, built our practice around this understanding. The patients who find their way to us have frequently tried multiple antidepressants, often for years, and still feel stuck. Their experience is not a failure of willpower; it reflects a biological reality about which neurotransmitter systems their depression is actually engaging.

How Neuroplasticity Becomes the Target

Neuroplasticity, the brain’s ability to reorganize itself by forming new neural connections, is not a static trait. It can be increased or decreased by environment, stress, illness, and treatment. Chronic depression is one of the more reliable ways to suppress it; effective treatment for depression is one of the more reliable ways to restore it.

Research shows that ketamine promotes neuroplasticity in ways that standard antidepressants do not, and does so rapidly, changes that SSRIs typically require weeks to approximate can appear within hours of a ketamine infusion (National Institutes of Health). This speed is clinically meaningful. For someone in the grip of severe depression, a week matters. For someone who has been waiting for months across multiple medication trials, the prospect of a different timeline is significant.

The mechanism behind this rapid effect runs through NMDA receptor blockade and the subsequent release of glutamate in a pattern that activates neuroplasticity pathways. In plain terms: ketamine briefly disrupts the brain’s usual signaling, and when that disruption resolves, the brain rebuilds connections in a healthier pattern. It is a reset, not a permanent fix achieved in a single session, but a meaningful opening that, with appropriate integration support, can be built upon.

What This Means for Treatment-Resistant Depression

For patients who have not responded to two or more antidepressant trials, the neuroscience strongly suggests the problem is not that they haven’t found the right serotonin medication. The problem may be that the serotonin system is not the primary driver of their depression at all.

Our IV ketamine infusions at Soft Reboot Wellness target the glutamate system directly, bypassing the serotonin pathway entirely and addressing the neuroplasticity deficit that standard medications leave untouched. A standard induction series involves four to six infusions over four to six weeks, with the protocol personalized to your response. We use the Osmind EHR platform for mood tracking throughout, so progress is documented rather than impressionistic. For patients who want to use the neuroplastic window opened by ketamine for deeper psychological work, our ketamine-assisted psychotherapy (KAP) program adds a preparation session and integration coaching.

We also work closely with patients’ existing treatment teams. If you have a psychiatrist or therapist, we coordinate with them, with your permission, because the neurobiological changes ketamine may produce are best consolidated through ongoing therapeutic work. Results vary by individual, and we encourage you to discuss whether ketamine therapy is appropriate for your specific history with your current healthcare provider.

Addressing the Fear of Starting Something New

One barrier we hear from patients often is not skepticism about the science. It is the exhaustion that comes from having tried things before and having them not work. After multiple medication trials, hope becomes a liability that feels too expensive to extend again.

We understand that. Dr. Herman and our team approach every new patient with the awareness that they are arriving with a history, not just a diagnosis. The initial intake process is designed to give us a thorough picture of what you have tried, for how long, and how you responded, so our recommendations are grounded in your actual trajectory, not a generic protocol. Treatment is not appropriate for everyone, and we will tell you honestly if we do not think we are the right fit.

The cost of ketamine therapy is a real consideration. IV ketamine for mental health is an off-label treatment, and insurance coverage is not standard. We recommend contacting our team at hello@softrebootwellness.com or 650-419-3330 to discuss the financial realities before your consultation, so there are no surprises on either side of the conversation.

Frequently Asked Questions

Can depression actually shrink your brain? Research suggests prolonged depression is associated with reduced volume in the hippocampus and other mood-regulating regions, likely due to the neurotoxic effects of chronic stress hormones and reduced BDNF levels (National Institutes of Health). These changes are not necessarily permanent, effective treatment, including approaches that promote neuroplasticity, may help restore some of this lost volume over time. Results vary by individual.

Why do antidepressants take so long to work if depression is a brain chemistry problem? SSRIs and SNRIs modulate neurotransmitter availability gradually, and the downstream structural changes that correspond with symptom improvement, including neuroplasticity shifts, take weeks to develop. The delay is a function of how those medications work at the synaptic level. Ketamine’s mechanism differs: it triggers a rapid glutamate release and neuroplasticity cascade that can produce antidepressant effects much faster, often within hours of infusion (National Institutes of Health).

Does everyone with depression have glutamate dysregulation? Not necessarily. Depression is not a single condition with a single mechanism. Glutamate dysregulation appears to be more prominent in treatment-resistant presentations, people who have not responded to serotonin-targeting medications. This is part of why we conduct a thorough review of your treatment history before recommending IV ketamine therapy.

How does cognitive fog from depression relate to brain changes? The memory and concentration difficulties many people experience with depression are tied to the same neurobiological changes that affect mood, particularly reduced hippocampal function and BDNF depletion. Effective treatment that addresses these underlying mechanisms may improve cognitive symptoms alongside mood, though results vary significantly between individuals.

Key Takeaways

• Depression produces measurable changes in brain chemistry and structure, including reduced BDNF, hippocampal atrophy, and glutamate system dysregulation. It is not simply a mood state.
• Standard antidepressants target the serotonin and norepinephrine systems; they may not adequately address glutamate dysregulation, which is common in treatment-resistant presentations.
• Neuroplasticity, the brain’s capacity to form new connections, is suppressed by chronic depression and can be rapidly restored by ketamine infusion.
• Our IV ketamine therapy at Soft Reboot Wellness in Menlo Park directly targets the glutamate-neuroplasticity pathway that many patients have not yet addressed.
• Results vary by individual; treatment candidacy is determined through a thorough medical and psychiatric review.

If your depression has not responded the way you hoped to standard treatment, the neuroscience suggests you are not broken, you may simply need treatment that works on a different system. We are glad to talk through whether that is something we can help with. Call us at 650-419-3330 or email hello@softrebootwellness.com to start the conversation.

References

1. Mayo Clinic. Symptoms and causes of major depressive disorder. https://www.mayoclinic.org/diseases-conditions/depression/symptoms-causes/syc-20356007
2. National Institutes of Health. Ketamine promotes neuroplasticity, the brain’s ability to form new neural connections, which may explain its rapid and sustained antidepressant effects. https://pmc.ncbi.nlm.nih.gov/articles/PMC8190578/
3. National Institutes of Health. Ketamine has been shown to increase brain-derived neurotrophic factor (BDNF), a protein essential for neuron growth and long-term mood regulation. https://pubmed.ncbi.nlm.nih.gov/39684808/
4. National Institutes of Health. Research documents the efficacy and limitations of SSRIs as a first-line treatment for depression and anxiety. https://pmc.ncbi.nlm.nih.gov/articles/PMC8395812/
5. National Institutes of Health. Research shows depression can impair memory and cognitive function, which may be improved with effective treatment. https://pmc.ncbi.nlm.nih.gov/articles/PMC5835184/

Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Treatment for depression, including IV ketamine therapy, should only be pursued under the supervision of a licensed medical provider familiar with your full medical and psychiatric history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.